Evidence map›Paper›PMID 10354287›Full record

ArticleKidney international1999

Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.

C Qiu, C Baylis

Open access · bronzeAbstract read
In one paragraph

Article in Kidney international, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 55 citations in OpenAlex.

  1. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms.American journal of physiology. Regulatory, integrative and comparative physiology · 2015
    Review
  2. Physiology of endothelin and the kidney.Comprehensive Physiology · 2011
    Review
  3. Review
  4. Article
  5. Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.American journal of physiology. Regulatory, integrative and comparative physiology · 2006
    Article
  6. Article
  7. Article
  8. Cyclic gmp is a measure of physiologic stress.Journal of the National Medical Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

C QiuDepartment of Physiology, Robert C. Byrd Health Sciences Center of West Virginia University, Morgantown, USA.
C Baylis
West Virginia University · US

Funding

NITRIC OXIDE NO AND THE KIDNEYR01DK045517 · NIDDK · WEST VIRGINIA UNIVERSITY · PI BAYLIS, CHRIS NONE · 1992 to 2003
$893k
NIDDK NIH HHS DK-45517NIDDK NIH HHS R01 DK045517
6 · The paper itself

Abstract

backgroundEndothelin (ET) and angiotensin mediate glomerular responses to systemic nitric oxide (NO) inhibition. Acute systemic NO synthase (NOS) inhibition in the rat causes marked increases in both preglomerular (RA) and efferent arteriolar (RE) resistances and a fall in the glomerular capillary ultrafiltration coefficient (Kf). In contrast, local intrarenal NOS inhibition increases RA, but has no effect on RE while producing a similar Kf lowering effect as seen with systemic NOS inhibition. These studies were designed to assess whether the increase in RE during systemic NOS inhibition is mediated by endogenous ET and whether angiotensin II (Ang II) also contributes.

methodsMicropuncture measurements were made before and during acute systemic NOS inhibition with N-monomethyl L-arginine (NMA) alone, NMA + the nonpeptide ETA and ETB receptor antagonist, bosentan, NMA + the Ang II type 1 receptor blocker, losartan, and NMA during combined bosentan and losartan.

resultsThe falls in single nephron glomerular filtration rate (SNGFR) and glomerular plasma flow seen with systemic NOS inhibition were prevented by concomitant administration of bosentan and losartan alone and in combination. The increases in systemic blood pressure (BP), glomerular BP (PGC), RA, and RE and the reduction in Kf seen with systemic NOS inhibition were attenuated by either bosentan or losartan. An attenuation in the elevation in total renal vascular resistance seen with systemic NOS inhibition was also observed with bosentan. Combined ET and Ang II type 1 blockade completely prevented the increase in systemic BP, PGC, and RE and the fall in Kf with systemic NOS inhibition, leaving only a very attenuated rise in RA.

conclusionsThese findings suggest that endogenous ET and Ang II partially mediate the glomerular hemodynamic responses (including the increased RE) to acute systemic NOS inhibition. The actions of ET and Ang II are mainly additive, and almost all of the vasoconstrictor responses to acute NOS inhibition are prevented when both vasoconstrictor systems are blocked.

Indexed as

Angiotensin IIAngiotensin Receptor AntagonistsAnimalsBosentanEndothelin-1Endothelin Receptor AntagonistsEnzyme InhibitorsKidney GlomerulusLosartanMaleNitric OxideNitric Oxide Synthaseomega-N-MethylarginineRatsRats, Sprague-DawleyRenal CirculationAngiotensin IIAngiotensin Receptor AntagonistsBosentanEndothelin-1Endothelin Receptor AntagonistsEnzyme InhibitorsLosartanNitric OxideNitric Oxide Synthaseomega-N-MethylarginineSulfonamides

Identifiers

PMID10354287
PMCPMC2757276
OpenAlexW1995340221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.